Linked Life Data

3158861

Source:http://linkedlifedata.com/resource/pubmed/id/3158861

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3158861rdf:typepubmed:Citationlld:pubmed
pubmed-article:3158861lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:3158861lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:3158861lifeskim:mentionsumls-concept:C0678222lld:lifeskim
pubmed-article:3158861lifeskim:mentionsumls-concept:C0023820lld:lifeskim
pubmed-article:3158861lifeskim:mentionsumls-concept:C0279025lld:lifeskim
pubmed-article:3158861lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:3158861lifeskim:mentionsumls-concept:C0443172lld:lifeskim
pubmed-article:3158861pubmed:issue2lld:pubmed
pubmed-article:3158861pubmed:dateCreated1985-7-22lld:pubmed
pubmed-article:3158861pubmed:abstractTextThe higher the low-density-lipoprotein cholesterol (beta lipoprotein) level, the greater the risk that coronary heart disease will develop, alpha-lipoprotein fractions (high-density-lipoproteins) are considered to be protective factors. Medroxyprogesterone acetate is responsible for characteristic changes of the lipoprotein patterns indicating enhanced coronary risks. Medroxyprogesterone acetate is applied in the therapy of breast, uterus and ovarian cancer. A statistically significant decrease was observed in alpha-lipoproteins whereas beta-lipoproteins increased without statistical significance. A similar reaction can be observed under the combination therapy of aminoglutethimide and medroxyprogesterone acetate, whereas the combination of cortisone and aminoglutethimide has a distinct influence on beta-lipoproteins but the alpha-lipoprotein level remains uninfluenced. According to these data the effect of an adjuvant application of these drugs must be carefully evaluated due to an increase of coronary risks.lld:pubmed
pubmed-article:3158861pubmed:languagegerlld:pubmed
pubmed-article:3158861pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3158861pubmed:citationSubsetIMlld:pubmed
pubmed-article:3158861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3158861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3158861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3158861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3158861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3158861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3158861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3158861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3158861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3158861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3158861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3158861pubmed:statusMEDLINElld:pubmed
pubmed-article:3158861pubmed:monthAprlld:pubmed
pubmed-article:3158861pubmed:issn0378-584Xlld:pubmed
pubmed-article:3158861pubmed:authorpubmed-author:SeidelDDlld:pubmed
pubmed-article:3158861pubmed:authorpubmed-author:WielandHHlld:pubmed
pubmed-article:3158861pubmed:authorpubmed-author:KuhnWWlld:pubmed
pubmed-article:3158861pubmed:authorpubmed-author:NagelG AGAlld:pubmed
pubmed-article:3158861pubmed:authorpubmed-author:CremerPPlld:pubmed
pubmed-article:3158861pubmed:authorpubmed-author:TeichmannA...lld:pubmed
pubmed-article:3158861pubmed:authorpubmed-author:KrushAAlld:pubmed
pubmed-article:3158861pubmed:authorpubmed-author:WanderH EHElld:pubmed
pubmed-article:3158861pubmed:issnTypePrintlld:pubmed
pubmed-article:3158861pubmed:volume8lld:pubmed
pubmed-article:3158861pubmed:ownerNLMlld:pubmed
pubmed-article:3158861pubmed:authorsCompleteYlld:pubmed
pubmed-article:3158861pubmed:pagination88-92lld:pubmed
pubmed-article:3158861pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:3158861pubmed:meshHeadingpubmed-meshheading:3158861-...lld:pubmed
pubmed-article:3158861pubmed:meshHeadingpubmed-meshheading:3158861-...lld:pubmed
pubmed-article:3158861pubmed:meshHeadingpubmed-meshheading:3158861-...lld:pubmed
pubmed-article:3158861pubmed:meshHeadingpubmed-meshheading:3158861-...lld:pubmed
pubmed-article:3158861pubmed:meshHeadingpubmed-meshheading:3158861-...lld:pubmed
pubmed-article:3158861pubmed:meshHeadingpubmed-meshheading:3158861-...lld:pubmed
pubmed-article:3158861pubmed:meshHeadingpubmed-meshheading:3158861-...lld:pubmed
pubmed-article:3158861pubmed:meshHeadingpubmed-meshheading:3158861-...lld:pubmed
pubmed-article:3158861pubmed:meshHeadingpubmed-meshheading:3158861-...lld:pubmed
pubmed-article:3158861pubmed:meshHeadingpubmed-meshheading:3158861-...lld:pubmed
pubmed-article:3158861pubmed:meshHeadingpubmed-meshheading:3158861-...lld:pubmed
pubmed-article:3158861pubmed:meshHeadingpubmed-meshheading:3158861-...lld:pubmed
pubmed-article:3158861pubmed:meshHeadingpubmed-meshheading:3158861-...lld:pubmed
pubmed-article:3158861pubmed:meshHeadingpubmed-meshheading:3158861-...lld:pubmed
pubmed-article:3158861pubmed:meshHeadingpubmed-meshheading:3158861-...lld:pubmed
pubmed-article:3158861pubmed:meshHeadingpubmed-meshheading:3158861-...lld:pubmed
pubmed-article:3158861pubmed:meshHeadingpubmed-meshheading:3158861-...lld:pubmed
pubmed-article:3158861pubmed:year1985lld:pubmed
pubmed-article:3158861pubmed:articleTitle[Changes in serum lipoproteins under hormonal therapy of breast carcinoma and other endocrine-dependent tumors].lld:pubmed
pubmed-article:3158861pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3158861pubmed:publicationTypeEnglish Abstractlld:pubmed